{
  "meta": {
    "title": "41_Transplant_Immunology",
    "url": "https://brainandscalpel.vercel.app/41-transplant-immunology-5bc88d7b.html",
    "scrapedAt": "2025-11-30T18:13:51.737Z"
  },
  "questions": [
    {
      "text": "A 45-year-old man with end-stage renal disease is scheduled for a kidney transplant. The best match for a donor kidney is from his identical twin brother. Which type of graft will this procedure involve?",
      "choices": [
        {
          "id": 0,
          "text": "Autograft"
        },
        {
          "id": 1,
          "text": "Isograft"
        },
        {
          "id": 2,
          "text": "Allograft"
        },
        {
          "id": 3,
          "text": "Xenograft"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>An <em>isograft</em> is a type of transplant where the donor and recipient are genetically identical, such as in the case of identical twins. Since there is no genetic difference between them, the transplant is not rejected by the recipient’s immune system.</p>\n\n<p> </p>\n\n<p><strong>Types of Grafts:</strong></p>\n\n<ul>\n\t<li><strong>Autograft </strong><strong>(Option A ruled out)</strong>\n\n\t<ul>\n\t\t<li>Graft taken from and used on the same individual.</li>\n\t</ul>\n\t</li>\n\t<li><strong>Isograft</strong>\n\t<ul>\n\t\t<li>Graft between genetically identical individuals (e.g., identical twins).</li>\n\t\t<li>No <span class=\"customMeta\" data-dictid=\"49e378f9f71692777197bc5e458569\">rejection</span> due to identical genetic makeup.</li>\n\t</ul>\n\t</li>\n\t<li><strong>Allograft</strong> (formerly <strong>Homograft</strong>) <strong>(Option C ruled out)</strong>\n\t<ul>\n\t\t<li>Graft between two genetically different individuals of the same species.</li>\n\t\t<li>Commonly used in clinical transplantation.</li>\n\t\t<li>Requires <span class=\"customMeta\" data-dictid=\"c3c986cd721692777189b473814b2e\">immunosuppressive</span> therapy to prevent rejection.</li>\n\t</ul>\n\t</li>\n\t<li><strong>Xenograft</strong> (formerly <strong>Heterograft</strong>) <strong>(Option D ruled out)</strong>\n\t<ul>\n\t\t<li>Graft between individuals of different species.</li>\n\t\t<li>Higher <span class=\"customMeta\" data-dictid=\"49e378f9f71692777197bc5e458569\">rejection</span> rate due to significant genetic differences.</li>\n\t</ul>\n\t</li>\n</ul>",
      "question_images": [],
      "explanation_video": null,
      "explanation_images": [],
      "explanation_audio_eng": null,
      "explanation_audio_hin": null
    },
    {
      "text": "In pre-transplant testing, which of the following methods is most commonly used to assess HLA compatibility between a kidney transplant donor and recipient?",
      "choices": [
        {
          "id": 0,
          "text": "Mixed Lymphocyte Reaction (MLR)"
        },
        {
          "id": 1,
          "text": "Microcytotoxicity Test"
        },
        {
          "id": 2,
          "text": "Histocompatibility Testing"
        },
        {
          "id": 3,
          "text": "ABO Blood Group Compatibility"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>The <span class=\"customMeta\" data-dictid=\"d67d13d7631692777192085decbefd\">Microcytotoxicity</span> Test</strong> is commonly used for <span class=\"customMeta\" data-dictid=\"b1debe2a7c16927771890479332d98\">HLA</span> typing. It identifies specific <span class=\"customMeta\" data-dictid=\"b1debe2a7c16927771890479332d98\">HLA</span> antigens on an individual's lymphocytes and uses antibodies against <span class=\"customMeta\" data-dictid=\"b1debe2a7c16927771890479332d98\">HLA</span> antigens to determine compatibility.</p>\n\n<p> </p>\n\n<p><strong>Pre-Transplant Testing and Matching:</strong></p>\n\n<ul>\n\t<li><strong>Histocompatibility Testing </strong><strong>(Option C ruled out)</strong>\n\n\t<ul>\n\t\t<li>Assesses <span class=\"customMeta\" data-dictid=\"9f961c54641692777184ddaf41886b\">compatibility</span> between donor and recipient to reduce <span class=\"customMeta\" data-dictid=\"a283380a9a1692777188549537a964\">graft</span> <span class=\"customMeta\" data-dictid=\"49e378f9f71692777197bc5e458569\">rejection</span> risk.</li>\n\t</ul>\n\t</li>\n\t<li><strong>ABO <span class=\"customMeta\" data-dictid=\"a3c99b36b6169277718332b20cc393\">Blood Group</span> <span class=\"customMeta\" data-dictid=\"9f961c54641692777184ddaf41886b\">Compatibility</span> </strong><strong>(Option D ruled out)</strong>\n\t<ul>\n\t\t<li>Essential for transplantation.</li>\n\t\t<li>Recipient’s <span class=\"customMeta\" data-dictid=\"a0e40688fa169277719572bdb48c92\">plasma</span> must not contain antibodies against the donor's <span class=\"customMeta\" data-dictid=\"8790b4667016927771979066e8958c\">RBC</span> antigens.</li>\n\t</ul>\n\t</li>\n\t<li><strong>HLA Compatibility</strong>\n\t<ul>\n\t\t<li>Key to <span class=\"customMeta\" data-dictid=\"44d3120c8f16927771815478ab1d1f\">allograft</span> success.</li>\n\t\t<li><strong>Human <span class=\"customMeta\" data-dictid=\"00346a7f211692777191e91c2af9fc\">Leukocyte</span> <span class=\"customMeta\" data-dictid=\"782b31281a1692777181708484c1d1\">Antigen</span> (HLA) System</strong>: Major <span class=\"customMeta\" data-dictid=\"5c1ca6b4d5169277718946805036fd\">histocompatibility</span> complex in humans.</li>\n\t\t<li>Matching <span class=\"customMeta\" data-dictid=\"b1debe2a7c16927771890479332d98\">HLA</span> antigens between donor and recipient improves <span class=\"customMeta\" data-dictid=\"a283380a9a1692777188549537a964\">graft</span> acceptance.</li>\n\t</ul>\n\t</li>\n\t<li><strong>HLA <span class=\"customMeta\" data-dictid=\"f31a3e05441692777201a8ce3ad560\">Typing</span> Methods</strong>\n\t<ul>\n\t\t<li><strong>Microcytotoxicity Test</strong>:\n\t\t<ul>\n\t\t\t<li>Uses antibodies to target specific <span class=\"customMeta\" data-dictid=\"b1debe2a7c16927771890479332d98\">HLA</span> antigens.</li>\n\t\t\t<li>Destruction of targeted cells indicates <span class=\"customMeta\" data-dictid=\"b1debe2a7c16927771890479332d98\">HLA</span> type.</li>\n\t\t</ul>\n\t\t</li>\n\t\t<li><strong>Molecular Methods</strong>:\n\t\t<ul>\n\t\t\t<li>Techniques like <strong>RFLP (Restriction Fragment Length Polymorphism)</strong> and <strong>PCR</strong> for precise <span class=\"customMeta\" data-dictid=\"b1debe2a7c16927771890479332d98\">HLA</span> gene identification.</li>\n\t\t</ul>\n\t\t</li>\n\t</ul>\n\t</li>\n\t<li><strong>Tissue Matching</strong>\n\t<ul>\n\t\t<li>After identifying HLA-compatible donors, tissue <span class=\"customMeta\" data-dictid=\"75e8739695169277719138884fec36\">matching</span> selects the most suitable donor.</li>\n\t\t<li><strong>Mixed <span class=\"customMeta\" data-dictid=\"c605d4126116927771916c2002638e\">Lymphocyte</span> Reaction (MLR)</strong>: <strong>(Option A ruled out)</strong>\n\t\t<ul>\n\t\t\t<li>Donor and recipient lymphocytes are cultured together.</li>\n\t\t\t<li>Incompatibility triggers the recipient’s T cells to undergo blast transformation, indicating <span class=\"customMeta\" data-dictid=\"49e378f9f71692777197bc5e458569\">rejection</span> risk.</li>\n\t\t</ul>\n\t\t</li>\n\t</ul>\n\t</li>\n</ul>",
      "question_images": [],
      "explanation_video": null,
      "explanation_images": [],
      "explanation_audio_eng": null,
      "explanation_audio_hin": null
    },
    {
      "text": "A 42-year-old woman is being considered for a liver transplant. Her doctors have found a donor with an identical ABO blood group but only partial HLA matching. Which additional test should be performed to assess compatibility further and reduce graft rejection risk?",
      "choices": [
        {
          "id": 0,
          "text": "Coombs cross-match"
        },
        {
          "id": 1,
          "text": "Microcytotoxicity test"
        },
        {
          "id": 2,
          "text": "Restriction Fragment Length Polymorphism (RFLP)"
        },
        {
          "id": 3,
          "text": "ABO blood group compatibility"
        }
      ],
      "correct_choice_id": 0,
      "solution": "<p><strong>Coombs cross-match</strong> is correct because it detects any pre-formed antibodies in the recipient's <span class=\"customMeta\" data-dictid=\"1ffaec13de169277719828374cfda0\">serum</span> against the donor's cells, ensuring better <span class=\"customMeta\" data-dictid=\"9f961c54641692777184ddaf41886b\">compatibility</span> and reducing the risk of rejection.</p>\n\n<p> </p>\n\n<p><strong>Ideal Versus Practical <span class=\"customMeta\" data-dictid=\"75e8739695169277719138884fec36\">Matching</span> in Transplantation:</strong></p>\n\n<ul>\n\t<li><strong>Histocompatibility Importance</strong>\n\n\t<ul>\n\t\t<li>Minimising <span class=\"customMeta\" data-dictid=\"331db7d96b16927771813cfafb0985\">antigenic</span> differences reduces <span class=\"customMeta\" data-dictid=\"a283380a9a1692777188549537a964\">graft</span> rejection.</li>\n\t\t<li>Perfect <span class=\"customMeta\" data-dictid=\"782b31281a1692777181708484c1d1\">antigen</span> <span class=\"customMeta\" data-dictid=\"75e8739695169277719138884fec36\">matching</span> is rarely achievable in practice.</li>\n\t</ul>\n\t</li>\n\t<li><strong>Ideal Matching</strong>\n\t<ul>\n\t\t<li>Ideally, the donor and recipient are genetically identical (isograft), eliminating <span class=\"customMeta\" data-dictid=\"49e378f9f71692777197bc5e458569\">rejection</span> risk.</li>\n\t\t<li>Rarely achievable except in identical twins.</li>\n\t</ul>\n\t</li>\n\t<li><strong>Practical Matching</strong>\n\t<ul>\n\t\t<li><strong>ABO Blood Group</strong>: Essential to match to avoid severe haemolytic reactions.</li>\n\t\t<li><strong>HLA System</strong>: Priority is given to <span class=\"customMeta\" data-dictid=\"75e8739695169277719138884fec36\">matching</span> HLA-A, -B, and -DR antigens, crucial for <span class=\"customMeta\" data-dictid=\"a283380a9a1692777188549537a964\">graft</span> survival.\n\t\t<ul>\n\t\t\t<li><strong>Sibling Donors</strong>: Best potential donors due to shared HLA haplotypes.</li>\n\t\t\t<li><strong>Unrelated Donors</strong>: Large registries help find matches, though perfect matches are less likely than with siblings.</li>\n\t\t</ul>\n\t\t</li>\n\t</ul>\n\t</li>\n\t<li><strong>Cross-Matching</strong>\n\t<ul>\n\t\t<li>Final cross-match detects recipient antibodies against donor cells.</li>\n\t\t<li>Techniques include <span class=\"customMeta\" data-dictid=\"894da1dfe6169277719871d7210619\">saline</span> cross-match and Coombs cross-match.</li>\n\t</ul>\n\t</li>\n\t<li><strong>Immunosuppressive Therapy</strong>\n\t<ul>\n\t\t<li>Lifelong therapy is essential to prevent <span class=\"customMeta\" data-dictid=\"a283380a9a1692777188549537a964\">graft</span> rejection.</li>\n\t\t<li>Uses a combination of drugs <span class=\"customMeta\" data-dictid=\"e4865847fa169277720044d7b530b0\">targeting</span> the immune system.</li>\n\t</ul>\n\t</li>\n</ul>\n\n<p><strong>Microcytotoxicity test (Option B)</strong> is incorrect as it is primarily used for determining HLA <span class=\"customMeta\" data-dictid=\"f31a3e05441692777201a8ce3ad560\">typing</span> rather than assessing pre-formed antibodies.</p>\n\n<p> </p>\n\n<p><strong>Restriction Fragment Length Polymorphism (RFLP) (Option C)</strong> is incorrect because it is a molecular method used for detailed genetic analysis, not for immediate <span class=\"customMeta\" data-dictid=\"9f961c54641692777184ddaf41886b\">compatibility</span> assessment.</p>\n\n<p> </p>\n\n<p><strong>ABO <span class=\"customMeta\" data-dictid=\"a3c99b36b6169277718332b20cc393\">blood group</span> <span class=\"customMeta\" data-dictid=\"9f961c54641692777184ddaf41886b\">compatibility</span> (Option D)</strong> is incorrect; while it is essential for safety, it has already been established as identical, and the focus should be on assessing antibodies to prevent rejection.</p>\n\n<p> </p>",
      "question_images": [],
      "explanation_video": null,
      "explanation_images": [],
      "explanation_audio_eng": null,
      "explanation_audio_hin": null
    },
    {
      "text": "A 55-year-old woman is undergoing a kidney transplant. During the pre-transplant evaluation, it is discovered that she has pre-existing antibodies against the donor’s HLA antigens due to a previous organ transplant. Which of the following is most likely to occur immediately after transplantation?",
      "choices": [
        {
          "id": 0,
          "text": "Acute cellular rejection"
        },
        {
          "id": 1,
          "text": "Hyperacute rejection"
        },
        {
          "id": 2,
          "text": "Chronic rejection"
        },
        {
          "id": 3,
          "text": "Graft-versus-host disease"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>Hyperacute <span class=\"customMeta\" data-dictid=\"49e378f9f71692777197bc5e458569\">rejection</span> </strong>occurs rapidly within hours of <span class=\"customMeta\" data-dictid=\"ee9f07b0a81692777200e416e4e5d7\">transplantation</span> when the recipient has pre-existing antibodies against the donor's antigens. This leads to immediate <span class=\"customMeta\" data-dictid=\"a283380a9a1692777188549537a964\">graft</span> failure.</p>\n\n<p> </p>\n\n<p><strong>Hyperacute Transplant Rejection:</strong></p>\n\n<ul>\n\t<li><strong>Definition</strong>\n\n\t<ul>\n\t\t<li>Rapid and severe <span class=\"customMeta\" data-dictid=\"49e378f9f71692777197bc5e458569\">rejection</span> occurring within hours of transplantation.</li>\n\t\t<li>Mediated by pre-existing antibodies in the recipient against donor antigens.</li>\n\t</ul>\n\t</li>\n\t<li><strong>Mechanism</strong>\n\t<ul>\n\t\t<li>Antibodies bind to antigens on the graft's endothelial cells.</li>\n\t\t<li>Activation of the <span class=\"customMeta\" data-dictid=\"f0ff39a3fa1692777184cf743ca1e7\">complement</span> <span class=\"customMeta\" data-dictid=\"6826aa04ef16927771833336e53730\">cascade</span> leads to:\n\t\t<ul>\n\t\t\t<li><strong>Thrombosis</strong>: Blood clots <span class=\"customMeta\" data-dictid=\"a1b06f401f1692777203a53393ba98\">form</span> in <span class=\"customMeta\" data-dictid=\"a283380a9a1692777188549537a964\">graft</span> vessels, <span class=\"customMeta\" data-dictid=\"9dc12b322016927771830dff673eeb\">blocking</span> <span class=\"customMeta\" data-dictid=\"82cc227a1c169277718387905b50c6\">blood flow</span> and causing ischemia.</li>\n\t\t\t<li><strong>Inflammation</strong>: <span class=\"customMeta\" data-dictid=\"000d23188716927771936c5f2fe74e\">Neutrophil</span> influx causes further <span class=\"customMeta\" data-dictid=\"a283380a9a1692777188549537a964\">graft</span> damage.</li>\n\t\t\t<li><strong>Necrosis</strong>: Tissue death due to <span class=\"customMeta\" data-dictid=\"0f670d10711692777190af4b12fac9\">ischemia</span> and inflammation.</li>\n\t\t</ul>\n\t\t</li>\n\t</ul>\n\t</li>\n\t<li><strong>Causes of Pre-existing Antibodies</strong>\n\t<ul>\n\t\t<li><strong>Prior Transplantation</strong>: Previous <span class=\"customMeta\" data-dictid=\"49e378f9f71692777197bc5e458569\">rejection</span> can lead to <span class=\"customMeta\" data-dictid=\"9d7a12cab116927771811a0079086d\">antibody</span> formation.</li>\n\t\t<li><strong>Blood Transfusion</strong>: Exposure to foreign antigens can sensitize recipients.</li>\n\t\t<li><strong>Pregnancy</strong>: Exposure to <span class=\"customMeta\" data-dictid=\"f375a3584316927772020efa386e3e\">fetal</span> antigens can trigger <span class=\"customMeta\" data-dictid=\"9d7a12cab116927771811a0079086d\">antibody</span> production.</li>\n\t</ul>\n\t</li>\n\t<li><strong>Characteristics</strong>\n\t<ul>\n\t\t<li>White <span class=\"customMeta\" data-dictid=\"a283380a9a1692777188549537a964\">graft</span> response: <span class=\"customMeta\" data-dictid=\"a283380a9a1692777188549537a964\">Graft</span> remains pale and is rapidly rejected without vascularisation.</li>\n\t</ul>\n\t</li>\n</ul>\n\n<p><strong>Prevention of <span class=\"customMeta\" data-dictid=\"c7c23b05e116927771899b5232b3d7\">Hyperacute</span> Rejection:</strong></p>\n\n<ul>\n\t<li><strong>Pre-transplant Screening</strong>\n\n\t<ul>\n\t\t<li>Essential to test for pre-existing antibodies against donor antigens (HLA and blood group).</li>\n\t</ul>\n\t</li>\n\t<li><strong>Cross-Matching</strong>\n\t<ul>\n\t\t<li>Final cross-match using recipient <span class=\"customMeta\" data-dictid=\"1ffaec13de169277719828374cfda0\">serum</span> and donor cells to detect last-minute incompatibilities.</li>\n\t</ul>\n\t</li>\n</ul>\n\n<p><strong>Treatment of <span class=\"customMeta\" data-dictid=\"c7c23b05e116927771899b5232b3d7\">Hyperacute</span> Rejection:</strong></p>\n\n<ul>\n\t<li><strong>Graft Removal</strong>\n\n\t<ul>\n\t\t<li>Difficult to treat; usually results in <span class=\"customMeta\" data-dictid=\"a283380a9a1692777188549537a964\">graft</span> loss.</li>\n\t\t<li>Prompt removal of the <span class=\"customMeta\" data-dictid=\"a283380a9a1692777188549537a964\">graft</span> is necessary to prevent complications.</li>\n\t</ul>\n\t</li>\n</ul>\n\n<p> </p>\n\n<table cellspacing=\"0\" style=\"border-collapse:collapse; width:740px\">\n\t<tbody>\n\t\t<tr>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p><strong>Type of rejection</strong></p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p><strong>Mechanism</strong></p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p><strong>Time after transplant</strong></p>\n\t\t\t</td>\n\t\t</tr>\n\t\t<tr>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p><strong>Hyperacute rejection</strong></p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p>Mediated by preformed antibodies specific for antigens on <span class=\"customMeta\" data-dictid=\"a283380a9a1692777188549537a964\">graft</span> endothelial cells, these may be natural <span class=\"customMeta\" data-dictid=\"e4a6fd7fbb169277718986a699e800\">IgM</span> antibodies specific for <span class=\"customMeta\" data-dictid=\"a3c99b36b6169277718332b20cc393\">blood group</span> antigens, or may be antibodies specific for <span class=\"customMeta\" data-dictid=\"812d0ddedb1692777181aaf62743b1\">allogeneic</span> <span class=\"customMeta\" data-dictid=\"99ed7c494c1692777192b0995e73f4\">MHC</span> molecules that were <span class=\"customMeta\" data-dictid=\"f3063c1d8b169277719018bf869980\">induced</span> by prior exposure of the organ recipient to <span class=\"customMeta\" data-dictid=\"812d0ddedb1692777181aaf62743b1\">allogeneic</span> cells through blood transfusions, pregnancy, or <span class=\"customMeta\" data-dictid=\"ee9f07b0a81692777200e416e4e5d7\">transplantation</span> of another organ</p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p>Minutes to hours</p>\n\t\t\t</td>\n\t\t</tr>\n\t\t<tr>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p><strong>Acute <span class=\"customMeta\" data-dictid=\"12a6f23332169277718402ca6703e2\">cellular</span> rejection</strong></p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p>CD8+ cells may directly destroy <span class=\"customMeta\" data-dictid=\"a283380a9a1692777188549537a964\">graft</span> cells, or CD4+ cells <span class=\"customMeta\" data-dictid=\"7b8c92219216927771981950fdd0e8\">secrete</span> cytokines and induce inflammation, which damages the graft</p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p>Anytime (most commonly first 6 months)</p>\n\t\t\t</td>\n\t\t</tr>\n\t\t<tr>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p><strong>Acute antibody-mediated (vascular, or humoral) rejection</strong></p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p>Antibodies bind to <span class=\"customMeta\" data-dictid=\"526ede3fee169277720184378acc5e\">vascular</span> <span class=\"customMeta\" data-dictid=\"b9a776cad316927771878445d3a99f\">endothelium</span> and <span class=\"customMeta\" data-dictid=\"dddc752e1716927771807f985bb8bb\">activate</span> <span class=\"customMeta\" data-dictid=\"f0ff39a3fa1692777184cf743ca1e7\">complement</span> via the classical pathway.</p>\n\n\t\t\t<p>The resultant <span class=\"customMeta\" data-dictid=\"e747a47db616927771908bff4b8931\">inflammation</span> and endothelial damage cause <span class=\"customMeta\" data-dictid=\"a283380a9a1692777188549537a964\">graft</span> failure.</p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\"> </td>\n\t\t</tr>\n\t\t<tr>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p><strong>Chronic rejection</strong></p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p>Chronic <span class=\"customMeta\" data-dictid=\"49e378f9f71692777197bc5e458569\">rejection</span> is an <span class=\"customMeta\" data-dictid=\"2c27fdf0ed1692777190530a17c849\">indolent</span> <span class=\"customMeta\" data-dictid=\"a1b06f401f1692777203a53393ba98\">form</span> of <span class=\"customMeta\" data-dictid=\"a283380a9a1692777188549537a964\">graft</span> damage that occurs over months or years, leading to progressive loss of <span class=\"customMeta\" data-dictid=\"a283380a9a1692777188549537a964\">graft</span> function.</p>\n\n\t\t\t<p>Chronic <span class=\"customMeta\" data-dictid=\"49e378f9f71692777197bc5e458569\">rejection</span> manifests as <span class=\"customMeta\" data-dictid=\"f46ba26d111692777190def3b1d80a\">interstitial</span> <span class=\"customMeta\" data-dictid=\"21e2d5a70616927772021fcdec0ca9\">fibrosis</span> and gradual narrowing of <span class=\"customMeta\" data-dictid=\"a283380a9a1692777188549537a964\">graft</span> blood vessels (graft arteriosclerosis).</p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p>Usually after 1st year</p>\n\t\t\t</td>\n\t\t</tr>\n\t</tbody>\n</table>\n\n<p> </p>\n\n<p><strong>Acute <span class=\"customMeta\" data-dictid=\"12a6f23332169277718402ca6703e2\">cellular</span> <span class=\"customMeta\" data-dictid=\"49e378f9f71692777197bc5e458569\">rejection</span> (Option A)</strong> is incorrect as it typically occurs days to weeks after transplantation, not immediately.</p>\n\n<p> </p>\n\n<p><strong>Chronic <span class=\"customMeta\" data-dictid=\"49e378f9f71692777197bc5e458569\">rejection</span> (Option C)</strong> is incorrect because it develops over months to years and is a slow process.</p>\n\n<p> </p>\n\n<p><strong>Graft-versus-host disease (Option D)</strong> is incorrect, as it occurs when donor immune cells attack the recipient’s tissues, usually associated with <span class=\"customMeta\" data-dictid=\"5b9831f3aa169277718395d7361df6\">bone marrow</span> transplants, not <span class=\"customMeta\" data-dictid=\"4aa6035df41692777190b41d4a1583\">kidney</span> transplants.</p>\n\n<p> </p>",
      "question_images": [],
      "explanation_video": null,
      "explanation_images": [],
      "explanation_audio_eng": null,
      "explanation_audio_hin": null
    },
    {
      "text": "A 45-year-old male recipient of a kidney transplant presents with a sudden increase in serum creatinine levels three days post-transplant. Laboratory tests reveal the presence of donor-specific antibodies (DSAs) and linear C4d staining in peritubular capillaries on biopsy. Which of the following statements best describes the condition?",
      "choices": [
        {
          "id": 0,
          "text": "It is primarily mediated by T-cell activation."
        },
        {
          "id": 1,
          "text": "It is characterized by the presence of pre-existing antibodies against donor antigens."
        },
        {
          "id": 2,
          "text": "It is commonly associated with chronic rejection mechanisms."
        },
        {
          "id": 3,
          "text": "It usually resolves spontaneously without intervention."
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>Correct Answer: B) It is characterized by the presence of pre-existing antibodies against donor antigens.</strong></p>\n\n<p><strong>Explanation:</strong></p>\n\n<p>Acute Humoral <span class=\"customMeta\" data-dictid=\"49e378f9f71692777197bc5e458569\">Rejection</span> (AHR) is diagnosed through the presence of donor-specific antibodies (DSAs) in the serum, along with <span class=\"customMeta\" data-dictid=\"1e9c8202241692777189dbac6cc062\">histological</span> evidence of <span class=\"customMeta\" data-dictid=\"58847ac05f16927771882c2b7f5367\">glomerulitis</span> or <span class=\"customMeta\" data-dictid=\"ce12dc160c1692777195473ab2cc21\">peritubular</span> <span class=\"customMeta\" data-dictid=\"a88db58e001692777183c88d89602f\">capillaritis</span> observed in <span class=\"customMeta\" data-dictid=\"754ab07a2e1692777183ed178c883d\">biopsy</span> samples. Additionally, <span class=\"customMeta\" data-dictid=\"d02067c4b51692777191b8eec8b062\">linear</span> C4d <span class=\"customMeta\" data-dictid=\"3b007026bd16927771997ae809b603\">staining</span> in <span class=\"customMeta\" data-dictid=\"ce12dc160c1692777195473ab2cc21\">peritubular</span> capillaries serves as a critical marker for confirming the diagnosis.</p>\n\n<p> </p>\n\n<p><strong>Acute Humoral <span class=\"customMeta\" data-dictid=\"49e378f9f71692777197bc5e458569\">Rejection</span> (AHR):</strong></p>\n\n<ul>\n\t<li><strong>Definition</strong>\n\n\t<ul>\n\t\t<li>Significant <span class=\"customMeta\" data-dictid=\"8a6b09beac1692777184b08a2b5766\">complication</span> in organ transplantation, particularly in <span class=\"customMeta\" data-dictid=\"4aa6035df41692777190b41d4a1583\">kidney</span> transplants.</li>\n\t\t<li>Characterized by donor-specific antibodies (DSAs) <span class=\"customMeta\" data-dictid=\"e4865847fa169277720044d7b530b0\">targeting</span> the <span class=\"customMeta\" data-dictid=\"526ede3fee169277720184378acc5e\">vascular</span> endothelium, leading to tissue injury and <span class=\"customMeta\" data-dictid=\"a283380a9a1692777188549537a964\">graft</span> dysfunction.</li>\n\t</ul>\n\t</li>\n</ul>\n\n<p><strong>Mechanisms of AHR:</strong></p>\n\n<ul>\n\t<li><strong>Pathophysiology</strong>\n\n\t<ul>\n\t\t<li>Binding of DSAs to donor HLA molecules activates the <span class=\"customMeta\" data-dictid=\"f0ff39a3fa1692777184cf743ca1e7\">complement</span> system, resulting in:\n\t\t<ul>\n\t\t\t<li><strong>Capillary Injury</strong>: Damage to <span class=\"customMeta\" data-dictid=\"ce12dc160c1692777195473ab2cc21\">peritubular</span> capillaries is a hallmark of AHR.</li>\n\t\t\t<li><strong>C4d Deposition</strong>: A key <span class=\"customMeta\" data-dictid=\"552e9ef8811692777186997018b858\">diagnostic</span> marker; approximately 30% of <span class=\"customMeta\" data-dictid=\"4cdc8161f71692777180df58cafa93\">acute</span> <span class=\"customMeta\" data-dictid=\"49e378f9f71692777197bc5e458569\">rejection</span> biopsies show widespread C4d staining.</li>\n\t\t\t<li><strong>Histological Features</strong>: May include <span class=\"customMeta\" data-dictid=\"041f0e547a1692777193350b3f7d39\">neutrophilic</span> infiltration, glomerulitis, and <span class=\"customMeta\" data-dictid=\"43b1f01822169277720222a3b354dd\">fibrinoid</span> <span class=\"customMeta\" data-dictid=\"5e84a7987c16927771931012aced83\">necrosis</span> in severe cases.</li>\n\t\t</ul>\n\t\t</li>\n\t</ul>\n\t</li>\n</ul>\n\n<p><strong>Diagnosis:</strong></p>\n\n<ul>\n\t<li><strong>Diagnostic Criteria</strong>\n\n\t<ul>\n\t\t<li>Combination of clinical presentation, serological testing, and histopathological findings:\n\t\t<ul>\n\t\t\t<li><strong>Histologic Evidence</strong>: <span class=\"customMeta\" data-dictid=\"58847ac05f16927771882c2b7f5367\">Glomerulitis</span> or <span class=\"customMeta\" data-dictid=\"ce12dc160c1692777195473ab2cc21\">peritubular</span> capillaritis.</li>\n\t\t\t<li><strong>Antibody Interaction</strong>: <span class=\"customMeta\" data-dictid=\"d02067c4b51692777191b8eec8b062\">Linear</span> C4d <span class=\"customMeta\" data-dictid=\"3b007026bd16927771997ae809b603\">staining</span> indicates recent <span class=\"customMeta\" data-dictid=\"9d7a12cab116927771811a0079086d\">antibody</span> interaction with <span class=\"customMeta\" data-dictid=\"526ede3fee169277720184378acc5e\">vascular</span> endothelium.</li>\n\t\t\t<li><strong>Detection of DSAs</strong>: Presence of DSAs in <span class=\"customMeta\" data-dictid=\"1ffaec13de169277719828374cfda0\">serum</span> confirms diagnosis.</li>\n\t\t</ul>\n\t\t</li>\n\t</ul>\n\t</li>\n</ul>\n\n<p><strong>Clinical Presentation:</strong></p>\n\n<ul>\n\t<li><strong>Symptoms</strong>\n\n\t<ul>\n\t\t<li>Patients may experience:\n\t\t<ul>\n\t\t\t<li><strong>Acute Elevation in Creatinine</strong>: Noted within days to weeks post-transplant.</li>\n\t\t\t<li><strong>Fever and Malaise</strong>: General <span class=\"customMeta\" data-dictid=\"8f2e7fd96116927771995b451b5c90\">systemic</span> <span class=\"customMeta\" data-dictid=\"e747a47db616927771908bff4b8931\">inflammation</span> signs.</li>\n\t\t\t<li><strong>Graft Tenderness</strong>: Possible <span class=\"customMeta\" data-dictid=\"169e1c9eb416927772006ea5a02252\">tenderness</span> over the transplant site.</li>\n\t\t</ul>\n\t\t</li>\n\t</ul>\n\t</li>\n</ul>\n\n<p><strong>Treatment:</strong></p>\n\n<ul>\n\t<li><strong>Management Approaches</strong>\n\n\t<ul>\n\t\t<li>Aim to reduce antibody-mediated injury:\n\t\t<ul>\n\t\t\t<li><strong>Plasmapheresis</strong>: Removes circulating antibodies.</li>\n\t\t\t<li><strong>Intravenous Immunoglobulin (IVIG)</strong>: Modulates immune responses.</li>\n\t\t\t<li><strong>Rituximab</strong>: Targets CD20 on B cells to reduce <span class=\"customMeta\" data-dictid=\"9d7a12cab116927771811a0079086d\">antibody</span> production.</li>\n\t\t\t<li><strong>Eculizumab</strong>: A <span class=\"customMeta\" data-dictid=\"f0ff39a3fa1692777184cf743ca1e7\">complement</span> <span class=\"customMeta\" data-dictid=\"b5fb56a28b1692777190396ae8b625\">inhibitor</span> effective in severe AHR cases.</li>\n\t\t</ul>\n\t\t</li>\n\t</ul>\n\t</li>\n</ul>\n\n<p><strong>It is primarily mediated by T-cell <span class=\"customMeta\" data-dictid=\"ba6b77f29316927771807350f86ce2\">activation</span> (Option A)</strong> is incorrect because AHR is primarily mediated by <span class=\"customMeta\" data-dictid=\"9d7a12cab116927771811a0079086d\">antibody</span> interactions, not T-cell responses.</p>\n\n<p> </p>\n\n<p><strong>It is commonly associated with <span class=\"customMeta\" data-dictid=\"8b6287a6e2169277718447e54e52b5\">chronic rejection</span> mechanisms (Option C)</strong> is incorrect since AHR is an <span class=\"customMeta\" data-dictid=\"4cdc8161f71692777180df58cafa93\">acute</span> process, distinct from chronic rejection.</p>\n\n<p> </p>\n\n<p><strong>It usually resolves spontaneously without intervention (Option D)</strong> is incorrect; AHR typically requires <span class=\"customMeta\" data-dictid=\"c3c986cd721692777189b473814b2e\">immunosuppressive</span> treatment for resolution.</p>\n\n<p> </p>",
      "question_images": [],
      "explanation_video": null,
      "explanation_images": [],
      "explanation_audio_eng": "https://image.prepladder.com/content/hOSJmMJTIpSfcIgGODru1745561828.mp3",
      "explanation_audio_hin": "https://image.prepladder.com/content/IMpbNQDyw1MUqZ6CoUJu1745561955.mp3"
    },
    {
      "text": "A patient presents with increased serum creatinine levels and graft tenderness shortly after a kidney transplant. A biopsy reveals lymphocytic infiltration in the graft tissue. Which of the following best describes the underlying mechanism of acute cellular rejection (ACR)?",
      "choices": [
        {
          "id": 0,
          "text": "Antibody-mediated destruction of the graft's vascular endothelium"
        },
        {
          "id": 1,
          "text": "Activation of recipient T-lymphocytes recognizing donor antigens"
        },
        {
          "id": 2,
          "text": "Activation of the complement system leading to tissue necrosis"
        },
        {
          "id": 3,
          "text": "Direct damage from pre-existing antibodies against donor cells"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>Acute <span class=\"customMeta\" data-dictid=\"12a6f23332169277718402ca6703e2\">cellular</span> <span class=\"customMeta\" data-dictid=\"49e378f9f71692777197bc5e458569\">rejection</span> (ACR) occurs when the recipient's T-lymphocytes recognize foreign antigens on the donor organ through direct and <span class=\"customMeta\" data-dictid=\"2f73e160ba1692777190d65065c95b\">indirect</span> pathways, leading to T-cell <span class=\"customMeta\" data-dictid=\"ba6b77f29316927771807350f86ce2\">activation</span> and <span class=\"customMeta\" data-dictid=\"669bdcb3111692777190e018ae930e\">infiltration</span> into the <span class=\"customMeta\" data-dictid=\"a283380a9a1692777188549537a964\">graft</span> tissue, causing damage.</p>\n\n<p> </p>\n\n<p><strong>Acute <span class=\"customMeta\" data-dictid=\"12a6f23332169277718402ca6703e2\">Cellular</span> <span class=\"customMeta\" data-dictid=\"49e378f9f71692777197bc5e458569\">Rejection</span> (ACR):</strong></p>\n\n<ul>\n\t<li>ACR is a significant concern in organ transplantation, characterized by T-lymphocyte <span class=\"customMeta\" data-dictid=\"669bdcb3111692777190e018ae930e\">infiltration</span> into transplanted tissue.</li>\n\t<li>Occurs within days to weeks post-transplant, mediated by the recipient’s T-lymphocytes recognizing foreign antigens on the donor organ.</li>\n</ul>\n\n<p><strong>Mechanisms of <span class=\"customMeta\" data-dictid=\"4cdc8161f71692777180df58cafa93\">Acute</span> <span class=\"customMeta\" data-dictid=\"12a6f23332169277718402ca6703e2\">Cellular</span> Rejection:</strong></p>\n\n<ul>\n\t<li><strong>T-cell Activation:</strong>\n\n\t<ul>\n\t\t<li><strong>Direct Pathway:</strong> Donor <span class=\"customMeta\" data-dictid=\"77f797c5e8169277718535480fa7fd\">dendritic</span> cells present antigens directly to recipient T-cells.</li>\n\t\t<li><strong>Indirect Pathway:</strong> Recipient antigen-presenting cells process and present donor antigens after donor cell death.</li>\n\t</ul>\n\t</li>\n\t<li><strong>Cytokine Release:</strong>\n\t<ul>\n\t\t<li>Activated T-cells release cytokines (e.g., IL-2, TNF-alpha, IFN-gamma), promoting <span class=\"customMeta\" data-dictid=\"e747a47db616927771908bff4b8931\">inflammation</span> and immune responses.</li>\n\t</ul>\n\t</li>\n</ul>\n\n<p><strong>Histopathological Features:</strong></p>\n\n<table cellspacing=\"0\" style=\"border-collapse:collapse; width:614px\">\n\t<tbody>\n\t\t<tr>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p><strong>Feature</strong></p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p><strong>Description</strong></p>\n\t\t\t</td>\n\t\t</tr>\n\t\t<tr>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:middle\">\n\t\t\t<p><strong>Lymphocytic Infiltration</strong></p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p>Predominantly CD4+ and CD8+ T-lymphocytes damage <span class=\"customMeta\" data-dictid=\"a283380a9a1692777188549537a964\">graft</span> tissue.</p>\n\t\t\t</td>\n\t\t</tr>\n\t\t<tr>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:middle\">\n\t\t\t<p><strong>Grading System</strong></p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p>Severity graded based on histology:</p>\n\t\t\t</td>\n\t\t</tr>\n\t\t<tr>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:middle\">\n\t\t\t<p><strong>Grade 0</strong></p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p>No rejection</p>\n\t\t\t</td>\n\t\t</tr>\n\t\t<tr>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:middle\">\n\t\t\t<p><strong>Grade 1R</strong></p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p>Mild <span class=\"customMeta\" data-dictid=\"669bdcb3111692777190e018ae930e\">infiltration</span> with minimal damage</p>\n\t\t\t</td>\n\t\t</tr>\n\t\t<tr>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:middle\">\n\t\t\t<p><strong>Grade 2R</strong></p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p>Moderate <span class=\"customMeta\" data-dictid=\"669bdcb3111692777190e018ae930e\">infiltration</span> with significant damage</p>\n\t\t\t</td>\n\t\t</tr>\n\t\t<tr>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:middle\">\n\t\t\t<p><strong>Grade 3R</strong></p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p>Severe <span class=\"customMeta\" data-dictid=\"89275101301692777186567d1912a0\">diffuse</span> <span class=\"customMeta\" data-dictid=\"669bdcb3111692777190e018ae930e\">infiltration</span> with extensive damage</p>\n\t\t\t</td>\n\t\t</tr>\n\t</tbody>\n</table>\n\n<p> </p>\n\n<p><strong>Clinical Presentation:</strong></p>\n\n<ul>\n\t<li><strong>Increased <span class=\"customMeta\" data-dictid=\"1ffaec13de169277719828374cfda0\">Serum</span> <span class=\"customMeta\" data-dictid=\"2ead0fd0301692777185187bd72768\">Creatinine</span> Levels:</strong> Indicative of <span class=\"customMeta\" data-dictid=\"4aa6035df41692777190b41d4a1583\">kidney</span> dysfunction.</li>\n\t<li><strong>Graft <span class=\"customMeta\" data-dictid=\"169e1c9eb416927772006ea5a02252\">Tenderness</span> or Pain:</strong> Common in <span class=\"customMeta\" data-dictid=\"4aa6035df41692777190b41d4a1583\">kidney</span> and heart transplants.</li>\n\t<li><strong>Fever and Malaise:</strong> Signs of <span class=\"customMeta\" data-dictid=\"8f2e7fd96116927771995b451b5c90\">systemic</span> inflammation.</li>\n</ul>\n\n<p><strong>Diagnosis:</strong></p>\n\n<ul>\n\t<li><strong>Serum <span class=\"customMeta\" data-dictid=\"2ead0fd0301692777185187bd72768\">Creatinine</span> Measurement:</strong> To assess <span class=\"customMeta\" data-dictid=\"b9356afdba16927771979d068c6587\">renal</span> function.</li>\n\t<li><strong>Biopsy of the Transplanted Organ:</strong> Evaluates for lymphocytic <span class=\"customMeta\" data-dictid=\"669bdcb3111692777190e018ae930e\">infiltration</span> and histopathological changes.</li>\n</ul>\n\n<p><strong>Treatment:</strong></p>\n\n<table cellspacing=\"0\" style=\"border-collapse:collapse; width:614px\">\n\t<tbody>\n\t\t<tr>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p><strong>Treatment</strong></p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p><strong>Description</strong></p>\n\t\t\t</td>\n\t\t</tr>\n\t\t<tr>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:middle\">\n\t\t\t<p><strong>Corticosteroids</strong></p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p>Administered intravenously to reduce inflammation.</p>\n\t\t\t</td>\n\t\t</tr>\n\t\t<tr>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:middle\">\n\t\t\t<p><strong>Anti-T-cell Antibodies</strong></p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p>E.g., <span class=\"customMeta\" data-dictid=\"6792c35f5d1692777181925cba18c5\">antithymocyte globulin</span> (ATG), and <span class=\"customMeta\" data-dictid=\"b2b82438d6169277719287eb450079\">monoclonal</span> antibodies (OKT3) <span class=\"customMeta\" data-dictid=\"e4865847fa169277720044d7b530b0\">targeting</span> T-cells.</p>\n\t\t\t</td>\n\t\t</tr>\n\t\t<tr>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:middle\">\n\t\t\t<p><strong>Supportive Therapies</strong></p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p>Prophylactic antibiotics to prevent infections during immunosuppression.</p>\n\t\t\t</td>\n\t\t</tr>\n\t</tbody>\n</table>\n\n<p> </p>\n\n<p><strong>Antibody-mediated destruction of the graft's <span class=\"customMeta\" data-dictid=\"526ede3fee169277720184378acc5e\">vascular</span> <span class=\"customMeta\" data-dictid=\"b9a776cad316927771878445d3a99f\">endothelium</span> (Option A)</strong> is characteristic of <span class=\"customMeta\" data-dictid=\"4cdc8161f71692777180df58cafa93\">acute</span> <span class=\"customMeta\" data-dictid=\"1a6d065f851692777189ba5533d1ef\">humoral</span> rejection, not ACR.</p>\n\n<p> </p>\n\n<p><strong>Activation of the <span class=\"customMeta\" data-dictid=\"f0ff39a3fa1692777184cf743ca1e7\">complement</span> system leading to tissue necrosis</strong> <strong>(Option C)</strong>: While the <span class=\"customMeta\" data-dictid=\"f0ff39a3fa1692777184cf743ca1e7\">complement</span> system is involved in some <span class=\"customMeta\" data-dictid=\"49e378f9f71692777197bc5e458569\">rejection</span> mechanisms, it is primarily associated with <span class=\"customMeta\" data-dictid=\"1a6d065f851692777189ba5533d1ef\">humoral</span> <span class=\"customMeta\" data-dictid=\"49e378f9f71692777197bc5e458569\">rejection</span> rather than the T-cell-mediated process of ACR.</p>\n\n<p> </p>\n\n<p><strong>Direct damage from pre-existing antibodies against donor cells (Option C)</strong>: Pre-existing antibodies play a role in <span class=\"customMeta\" data-dictid=\"c7c23b05e116927771899b5232b3d7\">hyperacute</span> rejection, not in the T-cell mediated process of ACR.</p>\n\n<p> </p>",
      "question_images": [],
      "explanation_video": null,
      "explanation_images": [],
      "explanation_audio_eng": null,
      "explanation_audio_hin": null
    },
    {
      "text": "Which factor is NOT typically associated with chronic transplant rejection?",
      "choices": [
        {
          "id": 0,
          "text": "A) Persistent low-grade immune response despite immunosuppressive therapy."
        },
        {
          "id": 1,
          "text": "Inflammation during the first year post-transplant."
        },
        {
          "id": 2,
          "text": "Antibody-mediated damage leading to tissue injury."
        },
        {
          "id": 3,
          "text": "Non-immune factors like infections and ischemia."
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>Inflammation during the first year post-transplant is a common occurrence and is usually associated with<strong> <span class=\"customMeta\" data-dictid=\"4cdc8161f71692777180df58cafa93\">acute</span> rejection</strong>. <span class=\"customMeta\" data-dictid=\"8b6287a6e2169277718447e54e52b5\">Chronic rejection</span> is a slower, more <span class=\"customMeta\" data-dictid=\"fc73a9e10016927771905d69184c24\">insidious</span> process that develops over time and is characterized by persistent immune response, antibody-mediated damage, and non-immune factors.</p>\n\n<p> </p>\n\n<p><strong>Chronic Transplant Rejection:</strong></p>\n\n<ul>\n\t<li><strong>Definition</strong>: Chronic transplant <span class=\"customMeta\" data-dictid=\"49e378f9f71692777197bc5e458569\">rejection</span> is a slow, progressive <span class=\"customMeta\" data-dictid=\"a1b06f401f1692777203a53393ba98\">form</span> of organ <span class=\"customMeta\" data-dictid=\"49e378f9f71692777197bc5e458569\">rejection</span> occurring years post-transplantation.</li>\n</ul>\n\n<p><strong>Characteristics of Chronic Transplant Rejection:</strong></p>\n\n<p> </p>\n\n<table cellspacing=\"0\" style=\"border-collapse:collapse; width:614px\">\n\t<tbody>\n\t\t<tr>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p><strong>Characteristic</strong></p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p><strong>Description</strong></p>\n\t\t\t</td>\n\t\t</tr>\n\t\t<tr>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:middle\">\n\t\t\t<p><strong>Gradual Decline in <span class=\"customMeta\" data-dictid=\"a283380a9a1692777188549537a964\">Graft</span> Function</strong></p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p>Slow deterioration of transplanted organ function over time.</p>\n\t\t\t</td>\n\t\t</tr>\n\t\t<tr>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:middle\">\n\t\t\t<p><strong>Fibrosis and Scarring</strong></p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p>Chronic <span class=\"customMeta\" data-dictid=\"e747a47db616927771908bff4b8931\">inflammation</span> leads to <span class=\"customMeta\" data-dictid=\"5d6dfa73b316927772028f3cd60f7f\">fibrous</span> tissue deposition, causing <span class=\"customMeta\" data-dictid=\"e9dcc3d4241692777198c7030bf313\">scarring</span> and loss of normal organ structure.</p>\n\t\t\t</td>\n\t\t</tr>\n\t\t<tr>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:middle\">\n\t\t\t<p><strong>Vascular Changes</strong></p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p>Thickening and narrowing of blood vessels in the graft, reducing <span class=\"customMeta\" data-dictid=\"82cc227a1c169277718387905b50c6\">blood flow</span> and causing tissue damage.</p>\n\t\t\t</td>\n\t\t</tr>\n\t</tbody>\n</table>\n\n<p> </p>\n\n<p><strong>Potential Contributing Factors:</strong></p>\n\n<ul>\n\t<li><strong>Chronic, <span class=\"customMeta\" data-dictid=\"5297b5833216927771910b7a85de53\">Low-Grade</span> Immune Response</strong>: Persistent <span class=\"customMeta\" data-dictid=\"dc6add5cf91692777189b30a6bae38\">immune response</span> despite <span class=\"customMeta\" data-dictid=\"c3c986cd721692777189b473814b2e\">immunosuppressive</span> therapy, causing ongoing <span class=\"customMeta\" data-dictid=\"e747a47db616927771908bff4b8931\">inflammation</span> and tissue damage. <strong>(Option A ruled out)</strong></li>\n\t<li><strong>Antibody-Mediated Damage</strong>: Antibodies bind to <span class=\"customMeta\" data-dictid=\"a283380a9a1692777188549537a964\">graft</span> cells, activating complement, leading to cell <span class=\"customMeta\" data-dictid=\"803b5ed1c8169277719190b446ac83\">lysis</span> and inflammation. <strong>(Option C ruled out)</strong></li>\n\t<li><strong>Non-Immune Factors</strong>: Infections, <span class=\"customMeta\" data-dictid=\"0f670d10711692777190af4b12fac9\">ischemia</span> (lack of blood flow), and medication <span class=\"customMeta\" data-dictid=\"d3323d4b271692777200122ea879e5\">toxicity</span> contribute to chronic <span class=\"customMeta\" data-dictid=\"a283380a9a1692777188549537a964\">graft</span> damage. <strong>(Option D ruled out)</strong></li>\n</ul>\n\n<p><strong>Challenges in Understanding and Managing Chronic Rejection:</strong></p>\n\n<p> </p>\n\n<table cellspacing=\"0\" style=\"border-collapse:collapse; width:614px\">\n\t<tbody>\n\t\t<tr>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p><strong>Challenge</strong></p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p><strong>Description</strong></p>\n\t\t\t</td>\n\t\t</tr>\n\t\t<tr>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:middle\">\n\t\t\t<p><strong>Complex and Multifactorial</strong></p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p>Involves multiple factors, complicating cause identification and therapy development.</p>\n\t\t\t</td>\n\t\t</tr>\n\t\t<tr>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:middle\">\n\t\t\t<p><strong>Limited Treatment Options</strong></p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p>Existing therapies focus on <span class=\"customMeta\" data-dictid=\"4cdc8161f71692777180df58cafa93\">acute</span> <span class=\"customMeta\" data-dictid=\"49e378f9f71692777197bc5e458569\">rejection</span> prevention; less effective for chronic rejection.</p>\n\t\t\t</td>\n\t\t</tr>\n\t\t<tr>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:middle\">\n\t\t\t<p><strong>Impact on Long-Term <span class=\"customMeta\" data-dictid=\"a283380a9a1692777188549537a964\">Graft</span> Survival</strong></p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p>Major cause of long-term <span class=\"customMeta\" data-dictid=\"a283380a9a1692777188549537a964\">graft</span> failure.</p>\n\t\t\t</td>\n\t\t</tr>\n\t</tbody>\n</table>",
      "question_images": [],
      "explanation_video": null,
      "explanation_images": [],
      "explanation_audio_eng": null,
      "explanation_audio_hin": null
    },
    {
      "text": "Which of the following statements about acute graft-versus-host disease (aGVHD) is true?",
      "choices": [
        {
          "id": 0,
          "text": "aGVHD typically manifests within the first 30 days post-transplant."
        },
        {
          "id": 1,
          "text": "The primary target organs affected are the skin, liver, and lungs."
        },
        {
          "id": 2,
          "text": "Corticosteroids are the first-line treatment for managing aGVHD."
        },
        {
          "id": 3,
          "text": "aGVHD is solely caused by mismatches in blood type between donor and recipient."
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>Corticosteroids, such as methylprednisolone, are the standard first-line treatment for managing <span class=\"customMeta\" data-dictid=\"4cdc8161f71692777180df58cafa93\">acute</span> graft-versus-host disease, with about 50% of patients responding adequately.</p>\n\n<p> </p>\n\n<p><strong>Acute Graft-Versus-Host Disease (aGVHD):</strong></p>\n\n<ul>\n\t<li><strong>Definition</strong>: aGVHD is a significant <span class=\"customMeta\" data-dictid=\"8a6b09beac1692777184b08a2b5766\">complication</span> following <span class=\"customMeta\" data-dictid=\"812d0ddedb1692777181aaf62743b1\">allogeneic</span> <span class=\"customMeta\" data-dictid=\"d2e0ab499c169277718886ab5a46bf\">hematopoietic</span> <span class=\"customMeta\" data-dictid=\"467c0b4fc016927771997e1043aeda\">stem cell transplantation</span> (HSCT) where donor immune cells attack the recipient's tissues.</li>\n\t<li><strong>Onset</strong>: Typically occurs within the first 100 days post-transplant, but late-onset cases may arise. <strong>(Option A ruled out)</strong></li>\n</ul>\n\n<p><strong>Pathophysiology:</strong></p>\n\n<ul>\n\t<li><strong>Mechanism</strong>:</li>\n</ul>\n\n<ol>\n\t<li><strong>Recognition of Host Tissues</strong>: Donor T cells identify host tissues as foreign. <strong>(Option D ruled out)</strong></li>\n\t<li><strong>Inflammatory Cascade</strong>: Leads to damage of host epithelial cells.</li>\n</ol>\n\n<p><strong>Primary Target Organs</strong>: <strong>(Option B ruled out)</strong></p>\n\n<p> </p>\n\n<table cellspacing=\"0\" style=\"border-collapse:collapse; width:462px\">\n\t<tbody>\n\t\t<tr>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p><strong>Organ</strong></p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p><strong>Symptoms</strong></p>\n\t\t\t</td>\n\t\t</tr>\n\t\t<tr>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p><strong>Skin</strong></p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p>Maculopapular rash</p>\n\t\t\t</td>\n\t\t</tr>\n\t\t<tr>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p><strong>Liver</strong></p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p>Elevated <span class=\"customMeta\" data-dictid=\"2d60c5a677169277718325a811dcf1\">bilirubin</span> levels and liver enzymes</p>\n\t\t\t</td>\n\t\t</tr>\n\t\t<tr>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p><strong>Gastrointestinal Tract</strong></p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p>Abdominal pain, diarrhea, nausea, vomiting</p>\n\t\t\t</td>\n\t\t</tr>\n\t</tbody>\n</table>\n\n<p><br />\n<strong>Phases of Pathophysiology</strong>:</p>\n\n<ol>\n\t<li><strong>Activation of Antigen-Presenting Cells (APCs)</strong>: Damage from <span class=\"customMeta\" data-dictid=\"e7e8b232581692777184eaae773f67\">conditioning</span> <span class=\"customMeta\" data-dictid=\"988bd8e7c71692777197b9f1d5d5ca\">regimen</span> releases <span class=\"customMeta\" data-dictid=\"9d21dd5d3116927771907405b181bc\">inflammatory</span> cytokines.</li>\n\t<li><strong>Donor T Cell Activation</strong>: <span class=\"customMeta\" data-dictid=\"8eedb6cec61692777196a6a3b93d3f\">Proliferation</span> and migration of donor T cells to target tissues.</li>\n\t<li><strong>Tissue Destruction</strong>: Activated T cells induce <span class=\"customMeta\" data-dictid=\"4bfa3e6f2c1692777181c53b124cf7\">apoptosis</span> and <span class=\"customMeta\" data-dictid=\"5e84a7987c16927771931012aced83\">necrosis</span> through <span class=\"customMeta\" data-dictid=\"0ac01cc0c31692777185cae5f28175\">cytokine</span> release (e.g., TNF-alpha, IL-114).</li>\n</ol>\n\n<p><strong>Diagnosis:</strong></p>\n\n<ul>\n\t<li><strong>Key <span class=\"customMeta\" data-dictid=\"552e9ef8811692777186997018b858\">Diagnostic</span> Criteria</strong>:\n\n\t<ul>\n\t\t<li><strong>Clinical Symptoms</strong>: Development of skin rash, <span class=\"customMeta\" data-dictid=\"b3a647ce2516927771881427f56c1d\">gastrointestinal</span> distress, or liver <span class=\"customMeta\" data-dictid=\"3662597407169277718640a12868f5\">dysfunction</span> within 100 days post-transplant.</li>\n\t\t<li><strong>Biopsy</strong>: <span class=\"customMeta\" data-dictid=\"1e9c8202241692777189dbac6cc062\">Histological</span> examination helps <span class=\"customMeta\" data-dictid=\"c9001edbf216927771860f3475b44c\">differentiate</span> aGVHD from other conditions (e.g., <span class=\"customMeta\" data-dictid=\"5cc2d9fac616927772021889ee6d52\">viral</span> infections, drug reactions).</li>\n\t</ul>\n\t</li>\n</ul>\n\n<p><strong>Staging of <span class=\"customMeta\" data-dictid=\"4cdc8161f71692777180df58cafa93\">Acute</span> GVHD</strong>:</p>\n\n<p> </p>\n\n<table cellspacing=\"0\" style=\"border-collapse:collapse; width:360px\">\n\t<tbody>\n\t\t<tr>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p><strong>Grade</strong></p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p><strong>Description</strong></p>\n\t\t\t</td>\n\t\t</tr>\n\t\t<tr>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p><strong>I</strong></p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p>Mild involvement</p>\n\t\t\t</td>\n\t\t</tr>\n\t\t<tr>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p><strong>II</strong></p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p>Moderate involvement</p>\n\t\t\t</td>\n\t\t</tr>\n\t\t<tr>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p><strong>III</strong></p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p>Severe involvement, poor prognosis</p>\n\t\t\t</td>\n\t\t</tr>\n\t\t<tr>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p><strong>IV</strong></p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p>Very severe involvement, high mortality risk</p>\n\t\t\t</td>\n\t\t</tr>\n\t</tbody>\n</table>\n\n<p> </p>\n\n<p><strong>Risk Factors:</strong></p>\n\n<ul>\n\t<li><strong>Donor-Recipient Compatibility</strong>: Mismatches in <span class=\"customMeta\" data-dictid=\"b1debe2a7c16927771890479332d98\">HLA</span> and minor <span class=\"customMeta\" data-dictid=\"5c1ca6b4d5169277718946805036fd\">histocompatibility</span> antigens increase risk.</li>\n\t<li><strong>Sex Mismatch</strong>: Higher risk when female donors are paired with male recipients, especially if previously pregnant or transfused.</li>\n\t<li><strong>Age of Recipient</strong>: Increased risk in older patients.</li>\n</ul>\n\n<p><strong>Treatment:</strong></p>\n\n<ul>\n\t<li><strong>Management Focus</strong>: <span class=\"customMeta\" data-dictid=\"498d3df3a416927771894f595a597a\">Immunosuppression</span> to <span class=\"customMeta\" data-dictid=\"a3b8e7d7ec1692777192646b2c8f69\">mitigate</span> the immune response.</li>\n\t<li><strong>First-Line Treatment</strong>:\n\t<ul>\n\t\t<li>Corticosteroids (e.g., methylprednisolone).</li>\n\t\t<li>Approximately 50% of patients respond adequately.</li>\n\t</ul>\n\t</li>\n\t<li><strong>Second-Line Treatments</strong>:\n\t<ul>\n\t\t<li>Janus <span class=\"customMeta\" data-dictid=\"9863da498e1692777190e1c6515b48\">kinase</span> inhibitors (e.g., ruxolitinib) for steroid-resistant cases.</li>\n\t\t<li>Lack of universally accepted standards for <span class=\"customMeta\" data-dictid=\"3790c638ab16927771970a0a41d3ab\">refractory</span> cases.</li>\n\t</ul>\n\t</li>\n\t<li><strong>Supportive Care</strong>: Essential for managing infections and nutritional needs related to <span class=\"customMeta\" data-dictid=\"b3a647ce2516927771881427f56c1d\">gastrointestinal</span> involvement.</li>\n</ul>",
      "question_images": [],
      "explanation_video": null,
      "explanation_images": [],
      "explanation_audio_eng": null,
      "explanation_audio_hin": null
    },
    {
      "text": "Which of the following statements about chronic graft-versus-host disease (cGVHD) is true?",
      "choices": [
        {
          "id": 0,
          "text": "cGVHD can present with symptoms resembling those of systemic lupus erythematosus."
        },
        {
          "id": 1,
          "text": "Skin manifestations may include erythema, hyperkeratosis, and desquamation."
        },
        {
          "id": 2,
          "text": "The condition is primarily associated with infections rather than immune dysregulation."
        },
        {
          "id": 3,
          "text": "Second-line treatments for cGVHD typically include high-dose corticosteroids."
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>Skin manifestations in chronic graft-versus-host disease (cGVHD) often include erythema, hyperkeratosis, and desquamation. These symptoms arise due to the immune-mediated attack on the skin by donor T cells, leading to <span class=\"customMeta\" data-dictid=\"e025d338b21692777184b4a309cbfb\">chronic inflammation</span> and tissue damage.</p>\n\n<p> </p>\n\n<p><strong>Chronic Graft-Versus-Host Disease (cGVHD):</strong></p>\n\n<p><strong>Definition</strong>: cGVHD is a significant <span class=\"customMeta\" data-dictid=\"8a6b09beac1692777184b08a2b5766\">complication</span> following <span class=\"customMeta\" data-dictid=\"812d0ddedb1692777181aaf62743b1\">allogeneic</span> <span class=\"customMeta\" data-dictid=\"d2e0ab499c169277718886ab5a46bf\">hematopoietic</span> <span class=\"customMeta\" data-dictid=\"467c0b4fc016927771997e1043aeda\">stem cell transplantation</span> (HSCT) and is a leading cause of <span class=\"customMeta\" data-dictid=\"9b7604d5461692777192546af7cabd\">morbidity</span> and mortality in transplant recipients. It occurs when donor immune cells recognize recipient tissues as foreign.</p>\n\n<p><strong>Pathophysiology:</strong></p>\n\n<ul>\n\t<li><strong>Mechanism</strong>:\n\n\t<ul>\n\t\t<li><strong>Immune Dysregulation</strong>: Donor T cells attack host tissues, leading to <span class=\"customMeta\" data-dictid=\"e025d338b21692777184b4a309cbfb\">chronic inflammation</span> and fibrosis. <strong>(Option C ruled out)</strong></li>\n\t\t<li><strong>Tissue Damage</strong>: Results in damage to various organs, resembling <span class=\"customMeta\" data-dictid=\"96ab11a06a16927771823151c8e471\">autoimmune</span> diseases.</li>\n\t</ul>\n\t</li>\n\t<li><strong>Onset</strong>: Typically occurs between 80 days and 2 years post-transplant; approximately 30% are classified as <span class=\"customMeta\" data-dictid=\"233d458dd316927771854358419c86\">de</span> novo cases.</li>\n</ul>\n\n<p><strong>Clinical Manifestations:</strong></p>\n\n<p> </p>\n\n<table cellspacing=\"0\" style=\"border-collapse:collapse; width:574px\">\n\t<tbody>\n\t\t<tr>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p><strong>Organ System</strong></p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p><strong>Symptoms</strong></p>\n\t\t\t</td>\n\t\t</tr>\n\t\t<tr>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:middle\">\n\t\t\t<p><strong>Skin</strong></p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p>Erythema, hyperkeratosis, <span class=\"customMeta\" data-dictid=\"0c693b3930169277719803a8b63545\">sclerodermatous</span> changes, desquamation</p>\n\t\t\t</td>\n\t\t</tr>\n\t\t<tr>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:middle\">\n\t\t\t<p><strong>Oral Cavity</strong></p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p>Xerostomia, oral ulcers, <span class=\"customMeta\" data-dictid=\"709f606559169277719175609747e4\">lichenoid</span> changes</p>\n\t\t\t</td>\n\t\t</tr>\n\t\t<tr>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:middle\">\n\t\t\t<p><strong>Eyes</strong></p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p>Sicca syndrome (dry eyes) and discomfort</p>\n\t\t\t</td>\n\t\t</tr>\n\t\t<tr>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:middle\">\n\t\t\t<p><strong>Liver</strong></p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p>Cholestatic changes (elevated liver enzymes and bilirubin)</p>\n\t\t\t</td>\n\t\t</tr>\n\t\t<tr>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:middle\">\n\t\t\t<p><strong>Lungs</strong></p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p>Bronchiolitis obliterans syndrome (respiratory complications)</p>\n\t\t\t</td>\n\t\t</tr>\n\t\t<tr>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:middle\">\n\t\t\t<p><strong>Gastrointestinal Tract</strong></p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p>Anorexia, dysphagia, malabsorption, weight loss</p>\n\t\t\t</td>\n\t\t</tr>\n\t</tbody>\n</table>\n\n<p><br />\n<strong>Other Manifestations</strong>: Polymyositis, serositis, and <span class=\"customMeta\" data-dictid=\"96ab11a06a16927771823151c8e471\">autoimmune</span> features (less common).</p>\n\n<p><strong>Diagnosis:</strong></p>\n\n<ul>\n\t<li><strong>Key <span class=\"customMeta\" data-dictid=\"552e9ef8811692777186997018b858\">Diagnostic</span> Aspects</strong>:\n\n\t<ul>\n\t\t<li><strong>Clinical Examination</strong>: Assess symptoms across multiple organ systems.</li>\n\t\t<li><strong>Biopsy</strong>: Skin or other tissue biopsies may confirm the diagnosis and exclude other conditions.</li>\n\t</ul>\n\t</li>\n\t<li><strong>NIH Criteria</strong>: Standardized criteria established for diagnosing and classifying cGVHD based on clinical manifestations.</li>\n</ul>\n\n<p><strong>Treatment:</strong></p>\n\n<ul>\n\t<li><strong>Management Focus</strong>: <span class=\"customMeta\" data-dictid=\"c3c986cd721692777189b473814b2e\">Immunosuppressive</span> therapies to control the immune response.</li>\n\t<li><strong>First-Line Therapy</strong>:\n\t<ul>\n\t\t<li>Corticosteroids are typically the first line of treatment; initial responses are common, but recurrences may occur upon tapering. <strong>(Option D ruled out)</strong></li>\n\t</ul>\n\t</li>\n</ul>\n\n<p><strong>Second-Line Therapies</strong>: <strong>(Option D ruled out)</strong></p>\n\n<p> </p>\n\n<table cellspacing=\"0\" style=\"border-collapse:collapse; width:509px\">\n\t<tbody>\n\t\t<tr>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p><strong>Options</strong></p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p><strong>Description</strong></p>\n\t\t\t</td>\n\t\t</tr>\n\t\t<tr>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p><strong>Calcineurin Inhibitors</strong></p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p>e.g., tacrolimus</p>\n\t\t\t</td>\n\t\t</tr>\n\t\t<tr>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p><strong>Mycophenolate Mofetil</strong></p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p>Commonly used immunosuppressant</p>\n\t\t\t</td>\n\t\t</tr>\n\t\t<tr>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p><strong>Newer Agents</strong></p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p>ibrutinib or <span class=\"customMeta\" data-dictid=\"ad75bfbb551692777197a48c533f09\">ruxolitinib</span> for steroid-refractory cases</p>\n\t\t\t</td>\n\t\t</tr>\n\t</tbody>\n</table>\n\n<p><br />\n<strong>Supportive Care</strong>: Essential for managing symptoms and complications, including infection treatment due to immunosuppression.</p>\n\n<p><strong>cGVHD can present with symptoms resembling those of <span class=\"customMeta\" data-dictid=\"8f2e7fd96116927771995b451b5c90\">systemic</span> <span class=\"customMeta\" data-dictid=\"ccd536a9071692777191f53538ca30\">lupus</span> erythematosus (Option A): </strong>While cGVHD can present with a variety of symptoms, it does not primarily resemble <span class=\"customMeta\" data-dictid=\"8f2e7fd96116927771995b451b5c90\">systemic</span> <span class=\"customMeta\" data-dictid=\"ccd536a9071692777191f53538ca30\">lupus</span> erythematosus; it is characterized by immune <span class=\"customMeta\" data-dictid=\"3704fc52401692777186c42775c9fb\">dysregulation</span> affecting multiple organs.</p>\n\n<p> </p>",
      "question_images": [],
      "explanation_video": null,
      "explanation_images": [],
      "explanation_audio_eng": null,
      "explanation_audio_hin": null
    },
    {
      "text": "Which of the following statements about post-transplant complications is true?",
      "choices": [
        {
          "id": 0,
          "text": "Allograft rejection primarily involves the activation of B lymphocytes leading to antibody production."
        },
        {
          "id": 1,
          "text": "Hyperacute rejection occurs immediately due to pre-existing antibodies in the recipient."
        },
        {
          "id": 2,
          "text": "Graft-versus-host reaction is less likely to occur in immunocompromised recipients."
        },
        {
          "id": 3,
          "text": "Hemolytic disease of the newborn is caused by maternal incompatibility with paternal blood group antigens."
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>Hyperacute <span class=\"customMeta\" data-dictid=\"49e378f9f71692777197bc5e458569\">rejection</span> occurs immediately after <span class=\"customMeta\" data-dictid=\"ee9f07b0a81692777200e416e4e5d7\">transplantation</span> due to pre-existing antibodies in the recipient. These antibodies recognize and bind to the antigens on the donor graft, leading to an <span class=\"customMeta\" data-dictid=\"4cdc8161f71692777180df58cafa93\">acute</span> <span class=\"customMeta\" data-dictid=\"dc6add5cf91692777189b30a6bae38\">immune response</span> that results in rapid <span class=\"customMeta\" data-dictid=\"a283380a9a1692777188549537a964\">graft</span> failure.</p>\n\n<p> </p>\n\n<p><strong>Post-Transplant Complications:</strong></p>\n\n<p> </p>\n\n<p><strong>Immune-Mediated Complications:</strong></p>\n\n<ul>\n\t<li><strong>Allograft Rejection</strong>:\n\n\t<ul>\n\t\t<li>Occurs when the recipient's immune system attacks the transplanted organ, recognizing it as foreign.</li>\n\t\t<li>Mediated primarily by T lymphocytes, leading to tissue damage and <span class=\"customMeta\" data-dictid=\"a283380a9a1692777188549537a964\">graft</span> failure. <strong>(Option A ruled out)</strong></li>\n\t</ul>\n\t</li>\n</ul>\n\n<p><strong>Types of <span class=\"customMeta\" data-dictid=\"44d3120c8f16927771815478ab1d1f\">Allograft</span> Rejection</strong>:</p>\n\n<p> </p>\n\n<table cellspacing=\"0\" style=\"border-collapse:collapse; width:574px\">\n\t<tbody>\n\t\t<tr>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p><strong>Type</strong></p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p><strong>Description</strong></p>\n\t\t\t</td>\n\t\t</tr>\n\t\t<tr>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:middle\">\n\t\t\t<p><strong>First-Set Rejection</strong></p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p>Initial <span class=\"customMeta\" data-dictid=\"49e378f9f71692777197bc5e458569\">rejection</span> episode after transplantation.</p>\n\t\t\t</td>\n\t\t</tr>\n\t\t<tr>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:middle\">\n\t\t\t<p><strong>Second-Set Rejection</strong></p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p>More rapid and aggressive response upon re-transplantation from the same donor due to <span class=\"customMeta\" data-dictid=\"6eec2212b91692777189b54f3d9066\">immunological</span> memory.</p>\n\t\t\t</td>\n\t\t</tr>\n\t\t<tr>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:middle\">\n\t\t\t<p><strong>Hyperacute Rejection</strong></p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p>Immediate <span class=\"customMeta\" data-dictid=\"a283380a9a1692777188549537a964\">graft</span> failure due to pre-existing antibodies in the recipient <span class=\"customMeta\" data-dictid=\"e4865847fa169277720044d7b530b0\">targeting</span> the graft.</p>\n\t\t\t</td>\n\t\t</tr>\n\t</tbody>\n</table>\n\n<ul>\n\t<li><strong>Graft-versus-Host (GVH) Reaction</strong>:\n\n\t<ul>\n\t\t<li>Transplanted immune cells (T cells) attack the recipient's tissues, the reverse of typical transplant rejection.</li>\n\t\t<li>More likely in <span class=\"customMeta\" data-dictid=\"a3cc9f976916927771895692a1a8a0\">immunocompromised</span> recipients (e.g., newborns, those on <span class=\"customMeta\" data-dictid=\"c3c986cd721692777189b473814b2e\">immunosuppressive</span> therapy). <strong>(Option C ruled out)</strong></li>\n\t\t<li>Can lead to severe conditions, such as <span class=\"customMeta\" data-dictid=\"e3e0527e4c16927771971991e1fbcf\">runt</span> disease in animals.</li>\n\t</ul>\n\t</li>\n\t<li><strong>Factors Influencing Rejection</strong>:\n\t<ul>\n\t\t<li>Histocompatibility antigens (particularly the <span class=\"customMeta\" data-dictid=\"b1debe2a7c16927771890479332d98\">HLA</span> system) play a crucial role.</li>\n\t\t<li>Matching donor and recipient <span class=\"customMeta\" data-dictid=\"b1debe2a7c16927771890479332d98\">HLA</span> types minimizes <span class=\"customMeta\" data-dictid=\"49e378f9f71692777197bc5e458569\">rejection</span> risk.</li>\n\t</ul>\n\t</li>\n</ul>\n\n<h4><strong>Complications Related to Blood Transfusions</strong></h4>\n\n<ul>\n\t<li><strong>Hemolytic <span class=\"customMeta\" data-dictid=\"cbb73554631692777200444a9ea263\">Transfusion</span> Reactions</strong>:\n\n\t<ul>\n\t\t<li>Occur when <span class=\"customMeta\" data-dictid=\"10dcdd93561692777190d73418c5a7\">incompatible</span> ABO and Rh blood groups are transfused.</li>\n\t\t<li>Can trigger an immune response, leading to <span class=\"customMeta\" data-dictid=\"248111ded81692777197946454db52\">red blood cell</span> destruction, <span class=\"customMeta\" data-dictid=\"4aa6035df41692777190b41d4a1583\">kidney</span> failure, or death.</li>\n\t</ul>\n\t</li>\n\t<li><strong>Hemolytic Disease of the Newborn</strong>: <strong>(Option D ruled out)</strong>\n\t<ul>\n\t\t<li>Rh <span class=\"customMeta\" data-dictid=\"722db2c56816927771903e6469e2dc\">incompatibility</span> between mother and <span class=\"customMeta\" data-dictid=\"421fecf0e21692777202704942ac48\">fetus</span> can lead to <span class=\"customMeta\" data-dictid=\"f375a3584316927772020efa386e3e\">fetal</span> <span class=\"customMeta\" data-dictid=\"248111ded81692777197946454db52\">red blood cell</span> destruction.</li>\n\t\t<li>Maternal <span class=\"customMeta\" data-dictid=\"4fe92aaac71692777198234aaa055a\">sensitization</span> to <span class=\"customMeta\" data-dictid=\"f375a3584316927772020efa386e3e\">fetal</span> Rh antigens during pregnancy leads to <span class=\"customMeta\" data-dictid=\"9d7a12cab116927771811a0079086d\">antibody</span> production that crosses the placenta.</li>\n\t</ul>\n\t</li>\n\t<li><strong>Infectious Complications</strong>:\n\t<ul>\n\t\t<li>Risks include transmission of <span class=\"customMeta\" data-dictid=\"aa279cf1f016927771903f195bb1b9\">infectious</span> agents (e.g., HIV, <span class=\"customMeta\" data-dictid=\"39867f177b16927771888cf43850d5\">hepatitis</span> B and C, syphilis, malaria) through transfusions, despite screening procedures.</li>\n\t</ul>\n\t</li>\n</ul>",
      "question_images": [],
      "explanation_video": null,
      "explanation_images": [],
      "explanation_audio_eng": null,
      "explanation_audio_hin": null
    }
  ]
}